Impact of TauroLock^™-HEP500 versus unfractionated heparin for prevention of catheter complications in children with malignancy: a prospective, randomized, controlled study.

At 6 months, IL-6 levels were slightly higher in the heparin group (9.8 ± 3.6 pg/mL) compared with the taurolidine–citrate group (8.3 ± 3.0 pg/mL), although this difference did not reach statistical significance (mean difference: 1.5 pg/mL; 95% CI − 3.1–0.1; p = 0.067). hs-CRP At baseline, hs-CRP values were comparable between groups (taurolidine–citrate: 3.9 ± 1.8 mg/L; heparin: 4.1 ± 2.0 mg/L; mean difference: 0.2 mg/L; 95% CI − 0.9–0.5; p = 0.582).

also in 111,027 other papers